EATBF yields 2567.39% · MRK yields 2.76%● Live data
📍 EATBF pulled ahead of the other in Year 1
Combined, EATBF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EATBF + MRK for your $10,000?
Eat & Beyond Global Holdings Inc. is a private equity and venture capital firm specializing in early stage, growth, expansion, buy-ins or buy-out investments. It focuses on investments in the plant-based protein and meat alternative food industry. It identifies and acquires equity in companies operating in the sectors of plant-based proteins, fermented proteins, cultured proteins/agriculture, food tech, and consumer packaged goods, as well as cell agriculture and other experimental projects. The firm prefers to invest in companies based in North America, Europe, Israel, and Asian and Latin American countries. It typically invests between $1 million and $10million over the initial 48-month deployment period with a minimum ownership goal of 5%+. It prefers to take majority stakes. Eat & Beyond Global Holdings Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada.
Full EATBF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.